Korean Bioventure Financing Continues Downward Spiral In Q3

Handful Of IPOs Amid Chilly Sentiment

 
• By Jung Won Shin

VC Investment in South Korea’s biopharma sector drops again as investors continue to shy away amid higher interest rates and reduced out-licensing deals.

downward spiral
Higher Interest Rates, Smaller Out-Licensing Deals Deteriorate Sentiment • Source: Shutterstock

More from South Korea

More from Focus On Asia